Selina Koch, PhD
Executive Editor, Head of Intelligence & Research, BioCentury
Selina directs BioCentury’s in-depth analytical articles, research and the generation of infographics, covering scientific, corporate and strategic content across the biomedical ecosystem. Selina has domain expertise across a wide range of topics relevant to drug developers, with particular expertise in neurology. She has written key coverage of Aduhelm, other Alzheimer’s disease therapies and drug development more broadly in neurodegenerative diseases. She’s also been a driver of coverage of the accelerated approval pathway, and is a major contributor to BioCentury’s annual Back to School project. She is a guest contributor to the BioCentury This Week podcast, and moderates panels on neurology drug development globally. Selina joined BioCentury in 2014 after conducting postdoctoral research at the University of California San Francisco on the role of synaptic plasticity in shaping the development of brain circuits. She holds a B.S. in Neurobiology and Behavior from the University of Washington and a Ph.D. in Neuroscience from UCSF.